NCT02799212View on ClinicalTrials.gov

Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

somatostatin infusion

postoperative somatostatin infusion during 5 days at 6mg/day, followed by one day at 3mg/day.

DRUG

placebo infusion

Placebo infusion (50ml of 0.9% NaCl/day) during 6 days.

Trial Locations (7)

69004

Hospices Civils de Lyon - Hôpital de la Croix Rousse, Lyon

Unknown

APHP - Hôpital Beaujon, Clichy

CHRU Lille - Hopital Huriez, Lille

APHM - Hôpital de la Timone, Marseille

CHU de Bordeaux - Hôpital Haut Lévèque, Pessac

CHU Rennes - Hôpital Pontchaillou, Rennes

CHU de Toulouse - Hopital Rangueil, Toulouse

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT02799212 - Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter